UNITED THERAPEUTICS Corp

UTHR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001237334-26-000004
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: CAUSEY CHRISTOPHER (Director)

Summary

Type

Sell

Net shares

-20

% of shares

-0.48%

Amount (USD)

$9,803

Insider confidence score

52.5 out of 100

Positive

  • Under Rule 10b5-1 trading plan
  • Small scheduled sell (<0.5% of shares)
  • Minimal sell amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-04

Code

M

Net shares

+20.0

Price per Share

$119.76

Amount (USD)

$2,395.20

Acquired/Disposed

Acquired

Shares Owned Before

4,190.0

Shares Owned After

4,210.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-20.0

Price per Share

$490.17

Amount (USD)

$9,803.37

Acquired/Disposed

Disposed

Shares Owned Before

4,210.0

Shares Owned After

4,190.0

Derivative Transactions

Transaction 1

Security

Stock Option

Action

Exercise

Date

2026-03-04

Code

M

Net shares

-20.0

Acquired/Disposed

Disposed

Shares Owned Before

6,320.0

Shares Owned After

6,300.0

Filing's footnotes

1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.

2. This transaction was executed in multiple trades at prices ranging from $490.12 to $490.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.